[Home ] [Archive]   [ فارسی ]  
:: Main :: About us :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 1, Issue 2 (Winter 2005) ::
Sci J Iran Blood Transfus Organ 2005, 1(2): 37-41 Back to browse issues page
Detection of serologic prevalence of anti-CMV antibodies in thalassemia major patients and blood donors
M. Aghaeipour * , F.A. Tarabadi , M. Shaeigan , G.R. Babaee
Abstract:   (27649 Views)

  Abstract

  

 Background and Objectives

 Cytomegalovirus (CMV)infection has been recognized as a complication of blood transfusion. Transfusion-related CMV infection produces dramatic problems in immunocompromised patients including organ transplantation recipients, AIDS patients under immunosuppressive therapy, thalassemia major patients, and premature neonates. Regarding the importance of this infection in multitransfused patients and differences in prevalence of transfusion – related CMV infection in various reports, especially in thalassemia major patients, we decided to detect and compare the prevalence of CMV antibodies in thalassemia patients and blood donors.

 

  Materials and Methods 

 In this study we detected anti-CMV antibodies (IgG,IgM) by Elisa technique. We tested these antibodies in 55 thalassemia major patients (45 non-splenectomized and 10 splenectomized) and 1040 healthy donors.

 

 Results

 Our results showed that anti-CMV IgG antibody was positive in 89.6% of control group and 100% of thalassamic group, thus indicating of no significant difference in these two groups. Anti-CMV IgM antibody was positive in 0.04% of control group and in 9.1% of thalassemic group showing a significant difference. The prevalence of this antibody was respectively 30% and 4.5% in splenectomized and non-splenectomized groups of patients.

  

 Conclusions

 Absence of significant difference of anti-CMV IgM antibody in patient and control group reflected high frequency of this infection in our population and also the importance of the use of leukocyte free products for high risk blood recipients. Moreover, the significant difference in anti-CMV IgM antibody in splenectomized and non-splenectomized patient groups is related to the role of spleen in clearance of infectious agents and production of IgM antibody in this organ

  

  

 Key words: Cytomegalovirus (CMV), Thalassemia major, Elisa, Blood donor, Anti-CMV antibodies 

Keywords: Cytomegalovirus (CMV), Thalassemia major, Elisa, Blood donor, Anti-CMV antibodies
Full-Text [PDF 284 kb]   (3606 Downloads)    
Type of Study: Research | Subject: General
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA code


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Aghaeipour M, Tarabadi F, Shaeigan M, Babaee G. Detection of serologic prevalence of anti-CMV antibodies in thalassemia major patients and blood donors. Sci J Iran Blood Transfus Organ. 2005; 1 (2) :37-41
URL: http://bloodjournal.ir/article-1-14-en.html


Volume 1, Issue 2 (Winter 2005) Back to browse issues page
فصلنامه پژوهشی خون Scientific Journal of Iran Blood Transfus Organ
The Scientific Journal of Iranian Blood Transfusion Organization - Copyright 2006 by IBTO
Persian site map - English site map - Created in 0.06 seconds with 32 queries by YEKTAWEB 3781